Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT03304704
Eligibility Criteria:
* INCLUSION CRITERIA:
* GENOTYPE ONLY COHORT
* Any age
* Known resident of Bancoumana or the surrounding villages
* Acceptance and signature of the written informed consent and the assent for children aged 12-17 years
* Willingness to allow stored laboratory specimens to be used for future research
* PARASITE SURVEILLANCE COHORT
* 6 months to 65 years of age
* Known resident of Bancoumana or the surrounding villages
* Willingness to allow stored laboratory specimens to be used for future research
* Acceptance and signature of the written informed consent and the assent for children aged 12-17 years
* DSF COHORT
* Aged between 5 and 65 years, inclusive
* Good general health as determined by review of medical history and/or clinical testing at the time of screening
* Known resident of Bancoumana or the surrounding villages
* Willingness to allow stored laboratory specimens to be used for future research
* Willingness to undergo DSF
* Acceptance and signature of the written informed consent and the assent for children aged 12-17 years
EXCLUSION CRITERIA:
* GENOTYPE ONLY COHORT
* Behavioral, cognitive, or psychiatric disease that in the opinion of the investigator affects the ability of the subject to understand and cooperate with the study protocol
* Other condition that, in the opinion of the investigator, would jeopardize the safety or rights of a volunteer participating in the trial or would render the subject unable to comply with the protocol
* PARASITE SURVEILLANCE CHORT
* Behavioral, cognitive, or psychiatric disease that in the opinion of the investigator affects the ability of the subject to understand and cooperate with the study protocol
* Other condition that, in the opinion of the investigator, would jeopardize the safety or rights of a volunteer participating in the trial or would render the subject unable to comply with the protocol
* Currently enrolled participant in protocol 17-I-N006 or another active LMIV/MRTC vaccine clinical trial
* DSF COHORT
* Behavioral, cognitive, or psychiatric disease that in the opinion of the investigator affects the ability of the subject to understand and cooperate with the study protocol
* Other condition that, in the opinion of the investigator, would jeopardize the safety or rights of a volunteer participating in the trial or would render the subject unable to comply with the protocol
* Currently enrolled participant in protocol 17-I-N006 or another LMIV/MRTC vaccine clinical trial
* History of severe reaction to mosquito bites
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
65 Years
Study:
NCT03304704
Study Brief:
Protocol Section:
NCT03304704